← All stocks

Pulmonx Corp

LUNG Net selling
CIK 0001127537 #4330 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$547.89K
$46.41K on a plan · $0.00 straight out of an exercise
Sold at will
$501.48K
54 of 55 sales
Net
−$547.89K
−$501.48K against sales at will

By person

13 insiders · 55 transactions
39.9×

Glendon E. French holds 39.9 times base salary in stock. $4.65M of shares against $116.19K in salary for 2025.

Salary from the company's own proxy. The shares are what Glendon E. French last reported holding, valued at $2.26, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
French Glendon E. III
President and CEO
$292.32K (10)
−$292.32K
2,056,134
4.79%
$4.65M
+84.6%
Lehman David Aaron
General Counsel
$88.50K (16)
−$88.50K
361,827
0.8425%
$817.73K
+77.9%
Radhakrishnan Srikanth
Chief Science & Techn. Officer
$69.51K (12)
−$69.51K
316,994
0.7381%
$716.41K
+74.9%
Rose Geoffrey Beran
Chief Commercial Officer
$51.14K (16)
−$51.14K
449,832
1.05%
$1.02M
+52.3%
Florin Daniel P
Director
$46.41K (1) scheduled
−$46.41K
133,910
0.3118%
$302.64K
+135.9%
Sung Derrick
COO and CFO
1,335,319
3.11%
$3.02M
+886.8%
Williamson Steven S.
PRESIDENT AND CEO
358,967
0.8358%
$811.27K
+59.9%
Joshi Mehul
Chief Financial Officer & PAO
208,489
0.4854%
$471.19K
+59.3%
Melenikiotou Georgia
Director
139,714
0.3253%
$315.75K
+123.3%
Mead Dana G Jr.
Director
139,714
0.3253%
$315.75K
+123.3%
Ferrari Richard
Director
127,024
0.2958%
$287.07K
+119.5%
Sullivan Tiffany
Director
115,199
0.2682%
$260.35K
+202.8%
Burns Thomas William
Director
113,399
0.2640%
$256.28K
+212.9%
Insider
Date
Role
Action
Shares
Price
Amount
Rose Geoffrey Beran
1 Sep 2026
Chief Commercial Officer
Sell
1,746
$2.26
$3.95K
Rose Geoffrey Beran
1 Sep 2026
Chief Commercial Officer
Sell
1,530
$2.26
$3.46K
Rose Geoffrey Beran
1 Sep 2026
Chief Commercial Officer
Sell
2,390
$2.26
$5.40K
Rose Geoffrey Beran
1 Sep 2026
Chief Commercial Officer
Sell
2,213
$2.26
$5.00K
Lehman David Aaron
1 Sep 2026
General Counsel
Sell
4,827
$2.26
$10.91K
Lehman David Aaron
1 Sep 2026
General Counsel
Sell
3,476
$2.26
$7.86K
Lehman David Aaron
1 Sep 2026
General Counsel
Sell
2,224
$2.26
$5.03K
Lehman David Aaron
1 Sep 2026
General Counsel
Sell
3,807
$2.26
$8.60K
Radhakrishnan Srikanth
1 Sep 2026
Chief Science & Techn. Officer
Sell
5,863
$2.26
$13.25K
Radhakrishnan Srikanth
1 Sep 2026
Chief Science & Techn. Officer
Sell
3,618
$2.26
$8.18K
Radhakrishnan Srikanth
1 Sep 2026
Chief Science & Techn. Officer
Sell
2,121
$2.26
$4.79K
Radhakrishnan Srikanth
1 Sep 2026
Chief Science & Techn. Officer
Sell
2,643
$2.26
$5.97K
French Glendon E. III
1 Sep 2026
President and CEO
Sell
37,784
$2.26
$85.39K
French Glendon E. III
1 Sep 2026
President and CEO
Sell
4,098
$2.26
$9.26K
French Glendon E. III
2 Jun 2026
President and CEO
Sell
13,511
$1.57
$21.21K
French Glendon E. III
1 Jun 2026
President and CEO
Sell
38,467
$1.54
$59.24K
French Glendon E. III
1 Jun 2026
President and CEO
Sell
4,171
$1.54
$6.42K
Rose Geoffrey Beran
1 Jun 2026
CHIEF COMMERCIAL OFFICER
Sell
2,254
$1.54
$3.47K
Rose Geoffrey Beran
1 Jun 2026
CHIEF COMMERCIAL OFFICER
Sell
2,434
$1.54
$3.75K
Rose Geoffrey Beran
1 Jun 2026
CHIEF COMMERCIAL OFFICER
Sell
1,557
$1.54
$2.40K
Rose Geoffrey Beran
1 Jun 2026
CHIEF COMMERCIAL OFFICER
Sell
1,778
$1.54
$2.74K
Lehman David Aaron
1 Jun 2026
GENERAL COUNSEL
Sell
4,915
$1.54
$7.57K
Lehman David Aaron
1 Jun 2026
GENERAL COUNSEL
Sell
3,539
$1.54
$5.45K
Lehman David Aaron
1 Jun 2026
GENERAL COUNSEL
Sell
2,264
$1.54
$3.49K
Lehman David Aaron
1 Jun 2026
GENERAL COUNSEL
Sell
3,876
$1.54
$5.97K
Radhakrishnan Srikanth
1 Jun 2026
Chief Science &Techn. Officer
Sell
5,969
$1.54
$9.19K
Radhakrishnan Srikanth
1 Jun 2026
Chief Science &Techn. Officer
Sell
3,684
$1.54
$5.67K
Radhakrishnan Srikanth
1 Jun 2026
Chief Science &Techn. Officer
Sell
2,153
$1.54
$3.32K
Radhakrishnan Srikanth
1 Jun 2026
Chief Science &Techn. Officer
Sell
2,691
$1.54
$4.14K
Lehman David Aaron
2 Mar 2026
GENERAL COUNSEL
Sell
4,051
$1.43
$5.79K
Lehman David Aaron
2 Mar 2026
GENERAL COUNSEL
Sell
2,590
$1.43
$3.70K
Lehman David Aaron
2 Mar 2026
GENERAL COUNSEL
Sell
4,433
$1.43
$6.34K
Lehman David Aaron
2 Mar 2026
GENERAL COUNSEL
Sell
1,163
$1.43
$1.66K
Rose Geoffrey Beran
2 Mar 2026
CHIEF COMMERCIAL OFFICER
Sell
2,911
$1.43
$4.16K
Rose Geoffrey Beran
2 Mar 2026
CHIEF COMMERCIAL OFFICER
Sell
1,861
$1.43
$2.66K
Rose Geoffrey Beran
2 Mar 2026
CHIEF COMMERCIAL OFFICER
Sell
2,125
$1.43
$3.04K
Rose Geoffrey Beran
2 Mar 2026
CHIEF COMMERCIAL OFFICER
Sell
835
$1.43
$1.19K
French Glendon E. III
2 Mar 2026
President and CEO
Sell
58,368
$1.43
$83.47K
French Glendon E. III
2 Mar 2026
President and CEO
Sell
6,737
$1.43
$9.63K
French Glendon E. III
2 Mar 2026
President and CEO
Sell
2,708
$1.43
$3.87K
Radhakrishnan Srikanth
2 Mar 2026
Chief Science &Techn. Officer
Sell
4,198
$1.43
$6.00K
Radhakrishnan Srikanth
2 Mar 2026
Chief Science &Techn. Officer
Sell
2,461
$1.43
$3.52K
Radhakrishnan Srikanth
2 Mar 2026
Chief Science &Techn. Officer
Sell
3,068
$1.43
$4.39K
Radhakrishnan Srikanth
2 Mar 2026
Chief Science &Techn. Officer
Sell
756
$1.43
$1.08K
Florin Daniel P
8 Dec 2025
Director
Sold on a plan
23,321
$1.99
$46.41K
Lehman David Aaron
1 Dec 2025
GENERAL COUNSEL
Sell
3,401
$1.57
$5.34K
Lehman David Aaron
1 Dec 2025
GENERAL COUNSEL
Sell
2,176
$1.57
$3.42K
Lehman David Aaron
1 Dec 2025
GENERAL COUNSEL
Sell
3,725
$1.57
$5.85K
Lehman David Aaron
1 Dec 2025
GENERAL COUNSEL
Sell
976
$1.57
$1.53K
Rose Geoffrey Beran
1 Dec 2025
CHIEF COMMERCIAL OFFICER
Sell
2,379
$1.57
$3.74K
Rose Geoffrey Beran
1 Dec 2025
CHIEF COMMERCIAL OFFICER
Sell
1,522
$1.57
$2.39K
Rose Geoffrey Beran
1 Dec 2025
CHIEF COMMERCIAL OFFICER
Sell
1,738
$1.57
$2.73K
Rose Geoffrey Beran
1 Dec 2025
CHIEF COMMERCIAL OFFICER
Sell
683
$1.57
$1.07K
French Glendon E. III
1 Dec 2025
President and CEO
Sell
6,281
$1.57
$9.86K
French Glendon E. III
1 Dec 2025
President and CEO
Sell
2,524
$1.57
$3.96K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 54
Transactions with no price 0
Shares from compensation/vesting 3,065,000
History held since 2 Oct 2020